In vitro and in vivo antileukemic activity of B43-pokeweed antiviral protein against radiation-resistant human B-cell precursor leukemia cells.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Blood

• Publication date

  1995-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V86.11.4228.BLOODJOURNAL86114228PMID 7492781
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Apoptosis in the pathogenesis and treatment of disease

  1995cited by this paper
• Leukemic cell growth in SCID mice as a predictor of relapse in high-risk B-lineage acute lymphoblastic leukemia.

  1995cited by this paper
• [Apoptosis in the pathogenesis and treatment of disease].

  1995cited by this paper
• Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases

  1995cited by this paper
• Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission.

  1994cited by this paper
• Human t(4;11)(q21;q23) acute lymphoblastic leukemia in mice with severe combined immunodeficiency.

  1994cited by this paper
• Intrinsic radiation resistance of primary clonogenic blasts from children with newly diagnosed B-cell precursor acute lymphoblastic leukemia.

  1993cited by this paper
• Radiation resistance of primary clonogenic blasts from children with acute lymphoblastic leukemia.

  1993cited by this paper
• Treatment of acute lymphoblastic leukemia. 30 years' experience at St. Jude Children's Research Hospital.

  1993cited by this paper
• Radiation damage repair capacity of primary clonogenic blasts in acute lymphoblastic leukemia.

  1993cited by this paper
• Pretransplantation burden of leukemic progenitor cells as a predictor of relapse after bone marrow transplantation for acute lymphoblastic leukemia.

  1993cited by this paper
• Human t(1;19)(q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency.

  1993cited by this paper
• Lack of CD24 antigen expression in B-lineage acute lymphoblastic leukemia is associated with intrinsic radiation resistance of primary clonogenic blasts

  1993cited by this paper
• DNA fragmentation and cytolysis in U937 cells treated with diphtheria toxin or other inhibitors of protein synthesis.

  1993cited by this paper
• Lack of CD24 antigen expression in B-lineage acute lymphoblastic leukemia is associated with intrinsic radiation resistance of primary clonogenic blasts.

  1993cited by this paper
• IMMUNOTOXINS FOR THE TREATMENT OF LEUKAEMIA

  1993cited by this paper
• Effective immunochemotherapy of CALLA+C mu+ human pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency using B43 (anti-CD19) pokeweed antiviral protein immunotoxin plus cyclophosphamide.

  1992cited by this paper
• Pokeweed antiviral protein: ribosome inactivation and therapeutic applications.

  1992cited by this paper
• In vivo efficacy of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin against human pre-B cell acute lymphoblastic leukemia in mice with severe combined immunodeficiency.

  1992cited by this paper
• Programmed cell death and apoptosis

  1991cited by this paper
• Apoptosis: The Molecular Basis of Cell Death

  1991cited by this paper
• Production of a pokeweed antiviral protein (PAP)-containing immunotoxin, B43-PAP, directed against the CD19 human B lineage lymphoid differentiation antigen in highly purified form for human clinical trials.

  1991cited by this paper
• Acute lymphoblastic leukemia: recent advances in biology and therapy.

  1989cited by this paper
• Radiobiological heterogeneity of leukemic lymphocyte precursors from acute lymphoblastic leukemia patients.

  1989cited by this paper
• Immunobiologic differences between normal and leukemic human B-cell precursors.

  1988cited by this paper
• Modified BFM therapy for children with previously untreated acute lymphoblastic leukemia and unfavorable prognostic features. Report of Children's Cancer Study Group Study CCG-193P.

  1988cited by this paper
• Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes.

  1987cited by this paper
• Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia.

  1987cited by this paper
• B-cell growth factor receptor expression and B-cell growth factor response of leukemic B cell precursors and B lineage lymphoid progenitor cells.

  1987cited by this paper
• The staging of childhood acute lymphoblastic leukemia: strategies of the Childrens Cancer Study Group and a three-dimensional technic of multivariate analysis.

  1986cited by this paper
• Differentiation-linked leukemogenesis in lymphocytes.

  1986cited by this paper
• Acute lymphoblastic leukemia in childhood.

  1985cited by this paper

• Plant-Derived Type I Ribosome Inactivating Protein-Based Targeted Toxins: A Review of the Clinical Experience

  2022cites this paper
• New Medical Applications of Plant Secondary Metabolites (From APR Volume 3)

  2018cites this paper
• Feasibility Study of a Novel Experimental Induction Protocol Combining B43-PAP (Anti-CD19) Immunotoxin With Standard Induction Chemotherapy in Children and Adolescents With Relapsed B-Lineage ALL: A Report From the Children’s Oncology Group

  2015cites this paper
• Immunotoxins Constructed with Ribosome-Inactivating Proteins and their Enhancers: A Lethal Cocktail with Tumor Specific Efficacy

  2014cites this paper
• An Overview on Animal Models of ALL

  2011cites this paper
• Xenograft models for the preclinical evaluation of new therapies in acute leukemia

  2007cites this paper
• In vivo models of childhood leukemia for preclinical drug testing.

  2007cites this paper
• Immunotoxins for targeted cancer therapy

  2006cites this paper
• CNS activity of Pokeweed Anti-viral Protein (PAP) in mice infected with Lymphocytic Choriomeningitis Virus (LCMV)

  2005cites this paper
• Targeting of cytotoxic peptides to haematological malignancies

  2005cites this paper
• Immunotoxins and other conjugates: pre-clinical studies.

  2004cites this paper
• Cytotoxicity and toxicity to animals and humans of ribosome-inactivating proteins.

  2004cites this paper
• Binding and Cytotoxicity of Conjugated and Recombinant Fusion Proteins Targeted to the Gonadotropin-Releasing Hormone Receptor

  2004cites this paper
• Defective Expression of Bruton's Tyrosine Kinase in Acute Lymphoblastic Leukemia

  2003cites this paper
• T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect.

  2003cites this paper
• Testing of new agents in childhood cancer preclinical models: meeting summary.

  2002cites this paper
• Virus resistance mediated by ribosome inactivating proteins.

  2000cites this paper
• Evaluation of temozolomide in a SCID mouse model of human B-cell precursor leukemia.

  1999cites this paper
• Pokeweed antiviral protein and its applications.

  1999cites this paper
• Use of the microculture kinetic assay of apoptosis to determine chemosensitivities of leukemias.

  1998cites this paper
• Reduced toxicity and broad spectrum resistance to viral and fungal infection in transgenic plants expressing pokeweed antiviral protein II

  1998cites this paper
• Prognostic significance of T-lineage leukemic cell growth in SCID mice: a Children's Cancer Group study.

  1998cites this paper
• Combined therapeutic efficacy of the thymidylate synthase inhibitor ZD1694 (Tomudex) and the immunotoxin B43(anti-CD19)-PAP in a SCID mouse model of human B-lineage acute lymphoblastic leukemia.

  1998cites this paper
• Prognostic significance of B-lineage leukemic cell growth in SCID mice: a Children's Cancer Group Study.

  1998cites this paper
• Distinct in vivo engraftment and growth patterns of t(1;19)+/E2A-PBX1+ and t(9;22)+/BCR-ABL+ human leukemia cells in SCID mice.

  1998cites this paper
• Chemosensitivities of Leukemias Use of the Microculture Kinetic Assay of Apoptosis to Determine

  1998cites this paper
• Treatment of human B-cell precursor leukemia in SCID mice by using a combination of the anti-CD19 immunotoxin B43-PAP with the standard chemotherapeutic drugs vincristine, methylprednisolone, and L-asparaginase.

  1998cites this paper
• Immunotoxins for targeted cancer therapy.

  1998cites this paper
• Primary blasts from infants with acute lymphoblastic leukemia cause overt leukemia in SCID mice.

  1998cites this paper
• Use of clinically relevant human-scid-mouse models in metastasis research.

  1997cites this paper
• Apoptosis and Acute Lymphocytic Leukemia in Children a

  1997cites this paper
• Long-term malignant hematopoiesis in human acute leukemia bone marrow biopsies implanted in severe combined immunodeficiency mice.

  1997cites this paper
• Pharmacokinetic features, immunogenicity, and toxicity of B43(anti-CD19)-pokeweed antiviral protein immunotoxin in cynomolgus monkeys.

  1997cites this paper
• Treatment of human B-cell precursor leukemia in SCID mice using a combination of the investigational biotherapeutic agent B43-PAP with cytosine arabinoside.

  1996cites this paper
• Induction of apoptosis by ribosome‐inactivating proteins and related immunotoxins

  1996cites this paper
• Toxicity profile of the investigational new biotherapeutic agent, B43 (anti-CD19)-pokeweed antiviral protein immunotoxin.

  1996cites this paper
• Severe combined immunodeficient mouse models of human leukemia.

  1996cites this paper
• BTK as a Mediator of Radiation-Induced Apoptosis in DT-40 Lymphoma B Cells

  1996cites this paper